Department of Health June 2015 updated October 2016
- The Accelerated Access Review aims to set out new pathways for the development of medicines and medical technology, ultimately to give NHS patients quicker access.
- To add international insight, the Review asked RAND Europe to conduct a study with the aim of identifying and gaining insight into international examples of best practice where the use of new drugs, devices and diagnostics were already being accelerated.
- An interim report (October 2015) identifies the drivers/enablers of innovation and barriers or systemic tensions perceived to be slowing access. Discussion with stakeholders identified five propositions to speed up access to transformative health technology that can change the lives of NHS patients. These are:
- Putting the patient centre stage
- Getting ahead of the curve
- Supporting all innovators
- Galvanising the NHS
- Delivering change
- Final Report (24 October 2016) Accelerated Access Review: Review of innovative medicines and medical technologies
- The final report, supported by the Wellcome Trust, describes the pathway to market for both strategically-important innovations and products with more incremental benefits and makes recommendations for each. The report makes recommendations on how each of the six steps in the production pathway could be streamlined and accelerated so that patients get access to the most innovative products more quickly and more cheaply.
